Otrivin nose drops 0.05% GSK treat nasal congestion, nasal congestion (10ml)

Dosage form Bottle x 10ml
Specifications Xylometazoline hydrochloride

Ingredient

Composition information	Content
Xylometazoline hydrochloride	0.05%

Uses

indications

Otrivin 0.05% drug is indicated in reduced nasal congestion related to common colds, allergic rhinitis and recurrence (including colds), sinusitis.

Pharmacological

xylometazoline belongs to the sympathetic group on the alpha-adrenergic receptors in the nasal mucosa. When used in the nose, it causes blood vessels in the nose, thereby reducing edema in the nasal mucosa and surrounding surrounding throat. It also reduces symptoms associated with increased mucus secretion and facilitates the excretion of obstructive secretions. This makes breathing through the nose easily in cases of stuffy nose.

The effect of Otrivin begins within two minutes and lasts up to 12 hours.

In a double blind study, controlled by salt solution in patients with common colds, the nose effect of Otrivin remains significantly (P

Otrivin tolerates well, even in patients with sensitive nasal mucosa, and does not affect the function of the feather in the mucosa.

In-Vitro studies have shown that xylometazoline reduces the infectious activity of rhinoviruses related to common colds in humans.

Otrivin contains excipients that help prevent nasal mucosa.

Otrivin has a balanced pH within the range found in the nasal cavity.

Dynamic pharmacokinetics

Xylometazoline concentration in plasma after use in the nose is very low and near the detection limit.

Before taking Otrivin nose drops 0.05% GSK treat nasal congestion, nasal congestion (10ml)

How to use

How to use a small nose solution:

clean the nose. nose. One person.

contraindicated use of 0.05% Otrivin for children under 6 years old.

Children from 6 years old to 12 years old (for all indications):

Small 1 to 2 drops on each side of the nose, 1 or 2 times a day.

Do not use more than 5 days without a doctor's advice.

It is recommended to be used for the last time before going to bed.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose? Hypertension may occur after hypotension. Young children may be more prone to poisoning than adults.

should take appropriate support measures on all patients who are suspected of overdose and indicate emergency symptom treatment under medical supervision when guaranteed. This will include monitoring patients for a few hours. In case of serious overdose causing cardiac arrest, resuscitation should be continued for at least 1 hour.

What to do when you forget 1 dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Note that it should not be used double the prescribed dose.

Side Effects

When using Otrivin 0.05%, you may experience unwanted effects (ADR).

Common, ADR> 1/100

Nervous disorders: headache.

Disorders of respiratory system, chest and mediastinum: dry nose or uncomfortable feeling in the nose.

Stomach - intestinal disorders: Nausea.

Systemic disorders and at the position of drug use: The feeling of burns on the spot of the drug.

Very rare, ADR

Immune system disorders: Hypersensitivity reactions (angiography, rash, itching).

Eye disorders: Airyal impairment.

Cardiovascular disorders: abnormal heart rate and increased heart rate.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using Otrivin 0.05, you need to read the instructions carefully and refer to the information below.

Contraindicated

Otrivin 0.05% contraindications in the following cases:

should not be used in patients with pituitary surgery through butterfly bone or epidural surgery.

Be cautious when using

as with other sympathetic drugs, Otrivin should be used carefully on the recipiently symbolic patients that are too sensitive to the active ingredients Adrenergic, manifested through signs such as insomnia, dizziness, tremor, arrhythmia or hypertension.

Please consult your doctor if:

These effects are harmful;

The cold of your cold or more severe or other problems appears.

Be cautious when using Otrivin in the case:

Hypertension, cardiovascular disease.

Like elsewhere vasoconstriction, Otrivin should not be used for more than 1 week continuously because after a long time of use, there may be congestion of the nasal mucosa and/or rhinitis.

Do not use Otrivin 0.05% for children under 1 year of age.

Children from 1 to 2 years old: used as prescribed by a doctor.

Children from 2 years old to 11 years old: under the supervision of adults.

The ability to drive and operate machinery

Otrivin does not affect or negligible on the ability to drive and operate machinery.

Pregnancy

Because it may have a systemic effect, caution should not use Otrivin during pregnancy.

The period of breastfeeding

There is no evidence of any adverse effects on breastfed babies. However, it is not known whether the xylometazoline is excreted in breast milk, so during breastfeeding should be cautious when using Otrivin and should only be used under the guidance of medical staff.

Drug interaction

Mao inhibitors: Xylometazoline may increase the effect of Mao inhibitors and can cause hypertension. Do not use xylometazoline in patients who are or have used Mao inhibitors over the past two weeks.

3.4 -round antidepressants: Do not use Xylometazoline simultaneously with three or four antidepressants and sympathetic drugs that can lead to an increase in the sympathetic effect of xylometazoline.

Storage

Storage below 30 ° C. Avoid heat.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.